Officer buying at Invictus MD Strategies (GENE)

Officer buying at Invictus MD Strategies (V:GENE)

Trevor Douglas Dixon, a Senior Officer and Director, acquired 1,250,000 Common Shares on a direct ownership basis at a price of $0.400 through a prospectus or prospectus exempt offering on July 9th, 2019. The insider also acquired 625,000 Warrants with an exercise price of $0.600 until July 9, 2021. This represents a $500,000 investment into the company's shares and an account share holdings change of 14.0%.

Invictus MD Strategies is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Invictus MD Strategies Corp is Canada-based company engaged in the field of alternative medicine. The Company is focused on two main verticals within the Canadian cannabis sector: Licensed Producers and AB Laboratories Inc. The Licensed Producers vertical, which is under the Access to Cannabis for Medical Purposes (ACMPR), comprises investment in Acreage Pharms Ltd, located in West-Central Alberta; AB Laboratories Inc vertical comprises investment in AB Laboratories Inc, located near Hamilton, Ontario, which has both its cultivation and sales license under ACMPR. Also, the Company is a main shareholder for Future Harvest Development Ltd, a fertilizer and nutrients manufacturer based in Kelowna, British Columbia.